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Abstract
Background:  Antigen epitopes provide valuable information useful for disease prevention,
diagnosis, and treatment. Recently, more and more databases focusing on different types of
epitopes have become available. Conformational epitopes are an important form of epitope formed
by residues that are sequentially discontinuous but close together in three-dimensional space.
These epitopes have implicit structural information, making them attractive for both theoretical
and applied biomedical research. However, most existing databases focus on linear rather than
conformational epitopes.
Description: We describe CED, a special database of well defined conformational epitopes. CED
provides a collection of conformational epitopes and related information including the residue
make up and location of the epitope, the immunological property of the epitope, the source antigen
and corresponding antibody of the epitope. All entries in this database are manually curated from
articles published in peer review journals. The database can be browsed or searched through a
user-friendly web interface. Most epitopes in CED can also be viewed interactively in the context
of their 3D structures. In addition, the entries are also hyperlinked to various databases such as
Swiss-Prot, PDB, KEGG and PubMed, providing wide background information.
Conclusion: A conformational epitope database called CED has been developed as an information
resource for investigators involved in both theoretical and applied immunology research. It
complements other existing specialised epitope databases. The database is freely available at http:/
/web.kuicr.kyoto-u.ac.jp/~ced
Background
Immune cells recognize epitopes (antigenic determi-
nants) rather than entire antigens. Epitopes are the
regions of an antigen that are bound by antigen-specific
membrane receptors on lymphocytes or to secreted anti-
bodies[1]. T-cells recognize T-cell epitopes, which are usu-
ally linear peptides derived from protein antigens and
presented by MHC molecules. B-cells and antibodies rec-
ognize B-cell epitopes, which can be complete, small
chemical compounds or components of larger macromol-
ecules such as nucleotides, lipids, glycans and proteins.
Epitopes from macromolecules, especially proteins, are
further classified into another two categories. The first,
termed linear epitopes, are segments composed of a con-
tinuous string of residues along the polymer chain. The
second, termed conformational epitopes, are constituted
by several sequentially discontinuous segments that are
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brought together by the folding of the antigen into its
native structure [1,2].
As the molecular basis of immune recognition and the
immune response, both kinds of epitope provide valuable
information that is useful for disease prevention [3], diag-
nosis[4,5], and treatment [6-10]. Many databases, focus-
ing on different kinds of epitopes, are available as a large
number of epitopes have been identified in the past 20
years. MHCPEP [11], SYFPEITHI[12], FIMM[13],
MHCBN[14], EPIMHC[15] are T cell oriented. Bcipep[16]
and Epitome[17] are B cell oriented. AntiJen[18] is a mul-
tifaceted database with entries on both T cell and B cell
epitopes. However, most existing databases focus on lin-
ear rather than conformational epitopes.
Despite this, as many as 90% of B-cell epitopes from
native proteins are conformational rather than linear [19-
22]. In one report, 10 monoclonal antibodies were pro-
duced against Helicobacter pylori vacuolating cytotoxin,
and all of them proved to react with conformational
epitopes [22]. As well as being very common, conforma-
tional epitopes may also have functional advantages over
linear epitopes. For example, human antibodies directed
to conformational epitopes neutralized a wider range of
human immunodeficiency virus isolates than human
antibodies directed to linear epitopes[23]. A better under-
standing of conformational epitopes can not only provide
useful information for new vaccine design [3] and new
diagnostic reagent development[5], but also will be of
great value in disease treatment, including against virus
infection and cancer [6-10]. Conformational epitopes
also have implicit structural information relating to the
antigen itself and the mode of binding, which make them
attractive to theoretical biology research.
It is money and labour intensive to identify a B cell
epitope in detail experimentally. To predict B cell epitopes
accurately based on sequence profiling has been a long
term goal of many groups. However, a recent report by
Blythe et al shows that even the best set of scales and
parameters performed only marginally better than ran-
dom[24]. This suggests that structural approaches and
conformational epitope prediction is vital. A conforma-
tional epitope prediction server became available
recently[25] which will help in conformational epitope
discovery, but to predict conformational epitopes accu-
rately is still a very difficult task. For this reason, only sev-
eral hundred conformational epitopes are currently well
defined. We would expect this number to expand rapidly
in the future and so it will be necessary to have a database
to store and manage all the experimentally well-defined
conformational epitopes. Such a specialised conforma-
tional epitope database will also be helpful for B cell
epitope prediction research.
In this paper, we describe the Conformational Epitope
Database (CED). It provides a curated dataset that can be
used to evaluate existing epitope prediction methods as
well as develop new and better algorithms for prediction.
It also complements other existing epitope databases and
provides a resource for applied biomedical research in dis-
ease prevention, diagnosis, and treatment.
Construction and content
The MySQL relational database management system is
used in CED to store, retrieve and manage the data. The
web interface between the user and CED are coded in PHP
with PEAR database abstraction layer support. All entries
in this database are sourced from articles published in
peer reviewed journals. Initially, exhaustive queries are
made to PubMed and ScienceDirect; returning more than
3000 references that are loaded into an EndNote reference
Table 1: Contents of CED database entries
Entry Field Description
Conformational epitope ID Unique identification of the epitope used in CED database.
Constitution and location Residues that constitute the epitope and their locations.
Epitope immunoproperty Immunological property of the epitope. For example, any epitope will be considered as neutralizing if the 
activity of its source antigen is blocked when binding to its corresponding antibody.
Corresponding antibody Antibody that recognizes and binds this conformational epitope.
Experimental method Experiment techniques used to identify this epitope, e.g. NMR.
Source antigen The name of the antigen on which the conformational epitope exists.
Sequence of source antigen Sequence ID of the source antigen in primary sequence databases such as SwissProt and GenBank; 
hyperlinked.
Structure of source antigen PDB ID of the source antigen; hyperlinked
Structure of Ag-Ab complex PDB ID of the source antigen-antibody complex; hyperlinked.
Chemoproperty of source antigen Chemical property of source antigen. If the source antigen is an enzyme, it is hyperlinked to KEGG enzyme.
Publication reference PubMed ID of article that report this epitope; hyperlinked.
Comments Miscellaneous information of the epitope. It is often about the location difference between the reference and 
the sequence database.BMC Immunology 2006, 7:7 http://www.biomedcentral.com/1471-2172/7/7
Page 3 of 8
(page number not for citation purposes)
database. The references are then filtered manually to
exclude articles that do not define a conformational
epitope or where the defined epitope is only at a very low
resolution or completeness. The remaining data is
checked and entered manually into CED.
Each entry in CED provides information about a given
conformational epitope. The information provided
includes:
(1) The residue constitution and location of the epitope
(2) The immunological property of the epitope
(3) The antibody that can bind to the epitope
(4) The experimental method used to identify the epitope
(5) The source antigen where the epitope exists
(6) The sequence of the source antigen
(7) The structure of the source antigen
(8) The structure of the antigen-antibody complex
(9) The chemical properties of the source antigen
(10) The references describing the epitope
(11) The comments and miscellaneous information
The full description of the entry fields is given Table 1. An
example entry is shown in Figure 1.
Currently, CED has 225 entries. The majority (213) are
epitopes from protein antigens, though the database also
includes 6 from nucleic acids, 5 from glycans and 1 from
lipid. 138 epitopes are from vertebrates, the majority from
human (109), the rest of the epitopes are from viruses
(54), bacteria (22), invertebrates (7), plants (2) and
unspecified (2).
Utility and discussion
Browsing epitopes in the CED
From the homepage of CED, users can find an introduc-
tion to conformational epitopes and CED. They can
An example entry of CED Figure 1
An example entry of CED.BMC Immunology 2006, 7:7 http://www.biomedcentral.com/1471-2172/7/7
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browse epitope records page by page and entry by entry.
When browsing CED, the entries appear in a summary
table at first. Only the conformational epitope ID and the
constitution and location field are shown, and the data is
ordered by the CED identification number (ID). Clicking
on an ID opens a new window that displays the informa-
tion for the selected epitope in detail. An example is
shown in Figure 1.
Searching epitopes in the CED
Users can also search CED for specific conformational
epitopes. A detailed help page for the search function is
provided. CED can be searched by any field in the entry
and by any combination of up to three of the fields. There
are three pulldown listboxes and two pairs of radio but-
tons on the search interface. A query is formed by selecting
one or more fields from the pulldown listbox and com-
bining them logically by "and" or "or" radio buttons. Key
words or strings, such as a partial protein sequence, the
name of an antigen, PDB ID of a structure, clone code of
a monoclonal antibody, author name or PMID of a refer-
ence are entered into the blank text forms. The HTML
form parses the criteria into SQL database queries. The ini-
tial results returned are formatted into a summary table as
described above. Selecting each ID in the summary table
opens a new window that displays the detailed informa-
tion of each epitope.
As an example, if one wanted to retrieve all well defined
conformational epitopes from human antigens that are
recognized by mouse antibodies and identified by X-ray
diffraction, you would first select search field "Source anti-
gen" from the pulldown listbox, input "human" into the
corresponding blank text form and then select the "and"
button. Then you would select the "Corresponding anti-
body" search field and input "mouse". Finally, you would
select "Experimental method" and input "X-ray diffrac-
tion". The operations above will make the search interface
appear as shown in Figure 2. After clicking on the "Search"
button, records fulfilling the requirements would appear
in a new window as shown in Figure 3.
Viewing epitopes in the CED
Most conformational epitopes in CED can be viewed
interactively in the context of the antigen-antibody com-
plex, antigen structure or known theoretical model, if they
have corresponding PDB structures. The visualization
function of CED is powered by Jmol. To view an epitope
in the context of its 3D structure can help users identify
important structural features and judge if entries defined
by non-structural methods are reasonable. When brows-
ing or searching the CED, entries that have PDB structures
will have a conspicuous view icon in both the summary
table and the entry table. Clicking the view icon will ini-
tialize the loading of the Jmol Java applet. By default,
Interface for searching CED and an example search operation Figure 2
Interface for searching CED and an example search operation.BMC Immunology 2006, 7:7 http://www.biomedcentral.com/1471-2172/7/7
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structures in CED are displayed as backbone colored by
secondary structure. After loading, users can turn on or
turn off the epitope segments, antigen chains, and anti-
body chains. When turned on, epitope segments "blink"
and are then displayed in spacefill mode colored by CPK.
Users can also zoom in, zoom out, move, spin, and rotate
the structure, or even measure distance, angle, and dihe-
dral angle. A help page for viewing epitopes can be found
through a link on the view page. An example visualisation
of CE0096 is shown in Figure 4.
Necessity of building a specialised conformational epitope 
database
Conformational epitopes can not only provide useful
information for new vaccine design [3] and new diagnos-
tic reagent development [5], but also will be of great value
in disease treatment, including against virus infection and
cancer [6-10]. For example, two conformational epitopes
in CED (CE0096 and CE0199) are targets of two FDA
approved drugs (Herceptin and Erbitux), which are effec-
tive in treating some cancers [6,9]. We need a specialised
database to store this kind of useful information. Confor-
mational epitopes also provide structural information
relating to the antigen itself, making them attractive to
theoretical biology research. A recent research clearly
shows the underperformance of existing linear B cell
epitope prediction methods [24], suggesting that struc-
tural approaches and conformational epitope prediction
is vital. Thus a specialised conformational epitope data-
base will be helpful for developing new B cell epitope pre-
diction methods.
Related databases
The existing epitope databases can be classified into four
main categories: T cell oriented such as MHCPEP[11],
SYFPEITHI[12], FIMM[13], MHCBN[14], EPIMHC[15]; B
cell oriented such as Bcipep[16] and Epitome[17]; single
pathogenic organism oriented such as the HIV Molecular
Immunology Database [26] and HCV Molecular Immu-
nology Database[27] ; multifaceted database such as Ant-
iJen[18] and IEDB[28]. IEDB is still under construction at
the time of writing.
An example search result table Figure 3
An example search result table.BMC Immunology 2006, 7:7 http://www.biomedcentral.com/1471-2172/7/7
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Compared with most existing epitope databases, the cur-
rent size of CED is limited. However, most existing
epitope databases are focused on collecting linear
epitopes; whereas CED only contains conformational
epitopes, which are often less well defined and are harder
to identify experimentally or theoretically. Many articles
report new conformational epitopes, but few are defined
completely and precisely enough for inclusion in CED.
Taking autoimmune epitopes as an example: In many
cases, the nature of the epitopes have often been succes-
sively defined and refined from the level of whole cellular
organelles (using immunofluorescence methods), to
identifying the macromolecule involved (immunoblot,
gene expression libraries), to epitope regions (truncated
cDNAs, peptide scanning), but few are identified at the
contact residue level [29]. Since data quality is vital in bio-
informatics research, the aim of CED is to provide high
quality, well defined conformational epitope informa-
tion. So conformational epitopes that are not defined
clearly are discarded which limits the database size.
Epitome[17], a very recently released B cell epitope data-
base has a similar size to CED. Epitome collects B cell
epitopes only from PDB structures and includes CDR
information. In contrast, CED is sourced from the litera-
ture and also has conformational epitopes defined by
methods other than X-ray diffraction and NMR, such as
scanning mutagenesis, overlapping peptides, and phage
display. Although CED and Epitome are similar they are
derived from different resources and so provide comple-
mentary information. We believe that a simple database,
such as CED, specialising in conformational epitopes has
value in conjunction with these more complex, less spe-
cialised, databases. Although our manual search proce-
An example visualisation of CE0096 Figure 4
An example visualisation of CE0096. Epitope CE0096 has 3 segments, which are displayed as spacefill colored by CPK; the 
other part of antigen is visualised as backbone colored by secondary structure. The antibody chains are displayed as spacefill 
colored by secondary structure.BMC Immunology 2006, 7:7 http://www.biomedcentral.com/1471-2172/7/7
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dure may have missed a few known conformational
epitopes, we believe that CED is an essentially complete
database of well defined conformational epitopes.
Future work
Firstly, like all other databases, errors will have occurred
during the data accumulation phase. We hope users will
send their feedback to help us maintain and revise CED in
future.
Secondly, we will scan newly published peer review arti-
cles for well defined or refined conformational epitopes
routinely. New epitopes will be added; and newly refined
epitopes will be updated. Due to the rapid progress of
techniques in this field, we expect that more and more
new conformational epitopes will be identified in the
future. Thus, both the quantity and quality of CED entries
will increase.
Lastly, we have noticed that a formal ontology of epitopes
has been developed and suggested recently[30]. To repre-
sent and communicate epitope information systemati-
cally and effectively, we will make the next release of CED
completely compatible with IEDB's ontology.
Conclusion
A conformational epitope database (CED) has been devel-
oped, which can be browsed or searched through a simple
user friendly web interface. It is an essentially complete
database of well defined conformational epitopes and
provides a complement to other existing specialised
epitope databases. CED is also hyperlinked to several
external databases, providing wide background informa-
tion for each entry. Though currently relatively small in
size, the data in CED provides valuable information for
disease prevention, diagnosis, and treatment. Thus, we
hope it will be an important information resource for
investigators involved in both theoretical and applied
immunology research.
Availability and requirements
The database is available at http://web.kuicr.kyoto-
u.ac.jp/~ced, suitable for most graphical web browsers
support Java applets and JavaScript. We have tested on the
Windows, Mac and Linux operating systems.
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